
Facilitating drug discovery against COVID-19
A collaboration between EMBL Grenoble and EBRIS scientists led to the characterisation of a new compound with promising activity against SARS-CoV-2 variants.
7 July 2023
A collaboration between EMBL Grenoble and EBRIS scientists led to the characterisation of a new compound with promising activity against SARS-CoV-2 variants.
7 July 2023
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive